Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
37957
CAS Number:
50847-11-5
Ibudilast
Purity:
≥ 98 % (HPLC)
Synonym(s):
3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine
Documents
$239.96 /20 mg
Taille
Request Bulk Quote
Informations sur le produit

Ibudilast is a versatile compound recognized for its potential applications in various therapeutic areas, particularly in the treatment of neurological disorders and inflammatory conditions. This unique molecule exhibits anti-inflammatory and neuroprotective properties, making it a valuable candidate for research in conditions such as multiple sclerosis and neuropathic pain. Its ability to modulate immune responses and inhibit phosphodiesterase activity enhances its relevance in developing treatments for chronic inflammatory diseases. Researchers have noted its efficacy in promoting neuroprotection, which could lead to advancements in therapies for neurodegenerative diseases.

In addition to its therapeutic potential, Ibudilast has garnered interest in the field of addiction treatment, particularly for its ability to reduce cravings and withdrawal symptoms in substance use disorders. Its multifaceted applications highlight its importance in both pharmaceutical research and clinical settings. With ongoing studies exploring its full range of benefits, Ibudilast stands out as a promising compound for professionals seeking innovative solutions in healthcare.

Numéro CAS 
50847-11-5
Formule moléculaire
C14H18N2O
Poids moléculaire 
230.31
Point de fusion 
54 - 58 °C
Informations générales
Numéro CAS 
50847-11-5
Formule moléculaire
C14H18N2O
Poids moléculaire 
230.31
Point de fusion 
54 - 58 °C
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Ibudilast is widely utilized in research focused on various applications across different fields:

  • Neurological Disorders: Ibudilast has shown promise in treating conditions such as multiple sclerosis and neuropathic pain by modulating neuroinflammation and promoting neuroprotection.
  • Respiratory Health: It is used in the management of asthma and chronic obstructive pulmonary disease (COPD) due to its ability to inhibit phosphodiesterase, leading to bronchodilation and reduced inflammation.
  • Drug Development: Researchers are exploring its potential as an adjunct therapy in combination with other medications to enhance efficacy and reduce side effects in chronic pain management.
  • Anti-Addiction Therapy: Ibudilast is being investigated for its effects on substance use disorders, particularly in reducing cravings and withdrawal symptoms, making it a candidate for addiction treatment protocols.
  • Cardiovascular Research: Its anti-inflammatory properties are being studied for potential applications in cardiovascular diseases, where inflammation plays a critical role in disease progression.

Citations